Related Experiment Videos
Potential for therapeutic gain from combined-modality treatment
1Department of Medicine, Princess Margaret Hospital Toronto, Ont., Canada.
Frontiers of Radiation Therapy and Oncology
|January 1, 1992
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit?
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Fatigue in people with localized colorectal cancer who do and do not receive chemotherapy: a longitudinal prospective study.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Should docetaxel be standard of care for patients with metastatic hormone-sensitive prostate cancer? Pro and contra.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy.
British journal of cancer·2015
Proton therapy in the clinic.
Frontiers of radiation therapy and oncology·2011
Proton therapy: clinical gains through current and future treatment programs.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiotherapy for prostate cancer: current results of a phase II trial.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy for gastrointestinal malignancies.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy for thoracic cancers: recommendations for patient selection, setup and therapy.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy: normal tissue and tumor control effects with large dose per fraction.
Frontiers of radiation therapy and oncology·2011
First-line sugemalimab plus chemotherapy for metastatic non-small-cell lung cancer: an updated cost-effectiveness analysis based on 4-year survival data.
Expert review of pharmacoeconomics & outcomes research·2026
Survival Benefit of ARSI Therapy in Japanese mCSPC: A Systematic Review and Meta-Analysis.
International journal of urology : official journal of the Japanese Urological Association·2026
Patterns of radiological response to procarbazine and CCNU polychemotherapy in patients with oligodendroglioma.
Neuro-oncology advances·2026